Video Education With Result Dependent dIsclosure
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Dana-Farber Cancer Institute
- Study ID
- NCT05225428
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Video Education — BEHAVIORALInvestigator-developed, professionally animated and produced 8-minute video (Video Education) summarizing the core educational components of a genetic counseling visit
- Genetic Counseling — BEHAVIORALStandard genetic counseling
Study Details
The overall study objective of this trial study is to identify and evaluate strategies to improve the accessibility of the video education with result dependent disclosure (VERDI) model, increasingly utilized as a pre-genetic testing (pretest) education alternative in clinical practice, to better serve a more diverse patient population at risk for hereditary cancers.
Key Dates
- Start date
- Aug 4, 2022
- Status verified
- Sep 2025
- Primary completion
- Aug 30, 2026
- Completion
- Oct 1, 2026
Study Design
- Enrollment
- 1,020 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: QUALITATIVE ASSESSMENTThis part of the research study involves watching a brief educational video about genetic testing for inherited cancer risk (about 8 minutes) before completing a short interview by video or telephone with trained researchers. This interview will be digitally recorded for later review. It is expected that about 20 people will take part in this part of the research study. In the larger part of the study that will happen after this part of the study, it is expected 1000 people will participate.
- Experimental: RCT-VERDIA randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling
- Experimental: RCT-Genetic CounselingA randomized controlled trial (RCT) will evaluate the VERDI model vs. standard genetic counseling
Primary Outcome Measure
Video Education Acceptability (Qualitative Interview Study) [ Time Frame: 3 Weeks ]
Central Contacts
- Huma Q. Rana, MD. MPH617) 632-6292
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Dana Farber Cancer Institute | Boston | Massachusetts | 02115 | Huma Q Rana, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Boston, MA
By condition
By specialty
By research site
Related Studies
- Circulating Tumor Cell Analysis in Patients With Localized Prostate Cancer Undergoing ProstatectomyRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Chemotherapy-induced Cognitive and Brain Changes in Older Adults With Breast CancerRecruiting · Massachusetts General Hospital · Boston, Massachusetts
- A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)PHASE1/PHASE2 · Recruiting · Merck Sharp & Dohme LLC · Aurora, Colorado